麻醉疼痛科指南

订阅

MedSci主页 / 所有栏目 / 麻醉疼痛科指南

2020 SFAR指南：肌松药和麻醉逆转

2020-02-20 法国麻醉和重症医学学会 Anaesth Crit Care Pain Med . 2020 Feb;39(1):125-142.

肌松药

2020年2月，法国麻醉和重症医学学会(SFAR)发布了肌松药和麻醉逆转指南，本文主要针对肌松药以及麻醉逆转药物的应用提供了31条指导建议，主要目的是改善麻醉期间肌松药以及麻醉逆转药物的应用。

中文标题：

2020 SFAR指南：肌松药和麻醉逆转

英文标题：

Guidelines on muscle relaxants and reversal in anaesthesia

发布机构：

法国麻醉和重症医学学会

发布日期：

2020-02-20

简要介绍：

2020年2月，法国麻醉和重症医学学会(SFAR)发布了肌松药和麻醉逆转指南，本文主要针对肌松药以及麻醉逆转药物的应用提供了31条指导建议，主要目的是改善麻醉期间肌松药以及麻醉逆转药物的应用。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 SFAR指南：肌松药和麻醉逆转.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1f6b51c001990a18, title=2020 SFAR指南：肌松药和麻醉逆转, enTitle=Guidelines on muscle relaxants and reversal in anaesthesia, guiderFrom=Anaesth Crit Care Pain Med . 2020 Feb;39(1):125-142., authorId=0, author=, summary=2020年2月，法国麻醉和重症医学学会(SFAR)发布了肌松药和麻醉逆转指南，本文主要针对肌松药以及麻醉逆转药物的应用提供了31条指导建议，主要目的是改善麻醉期间肌松药以及麻醉逆转药物的应用。, cover=https://img.medsci.cn/20201016/1602854213390_2020535.jpg, journalId=0, articlesId=null, associationId=806, associationName=法国麻醉和重症医学学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Feb 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年2月，法国麻醉和重症医学学会(SFAR)发布了肌松药和麻醉逆转指南，本文主要针对肌松药以及麻醉逆转药物的应用提供了31条指导建议，主要目的是改善麻醉期间肌松药以及麻醉逆转药物的应用。</p> </div> </div> </div>, tagList=[TagDto(tagId=17005, tagName=肌松药)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=17005, guiderKeyword=肌松药, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3969, appHits=308, showAppHits=0, pcHits=1344, showPcHits=3661, likes=2, shares=61, comments=20, approvalStatus=1, publishedTime=Fri Oct 16 22:16:31 CST 2020, publishedTimeString=2020-02-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Oct 16 21:17:01 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:50:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 SFAR指南：肌松药和麻醉逆转.pdf)])
2020 SFAR指南：肌松药和麻醉逆转.pdf
下载请点击：
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1078428, encodeId=959510e842884, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/9af4f46ea6004869aea23fabb77f1614/d23125a977bc473e96b379a9b303d1a0.jpg, createdBy=8500100443, createdName=woshibaitu, createdTime=Thu Dec 09 14:03:55 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977261, encodeId=fd359e72615f, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Sun Jun 27 12:04:46 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973753, encodeId=4d189e37538e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210615/2ee3fac9632a4d1fb90fb66f0c69d51e/676a24ca6b3948adaaf4522dd9f1a6f7.jpg, createdBy=09995521365, createdName=ms9000001134969034, createdTime=Tue Jun 15 15:59:52 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973664, encodeId=dd679e366410, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ff45503249, createdName=ms2000000300346599, createdTime=Tue Jun 15 10:18:07 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962992, encodeId=bf0696299266, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/deb9cbd849f8496eb91e945a9b30c8c9/47210eaeb9a14963a5f35bdd95998a3c.jpg, createdBy=85962545734, createdName=ddrrrr13, createdTime=Thu May 06 08:40:46 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-12-09 woshibaitu

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1078428, encodeId=959510e842884, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/9af4f46ea6004869aea23fabb77f1614/d23125a977bc473e96b379a9b303d1a0.jpg, createdBy=8500100443, createdName=woshibaitu, createdTime=Thu Dec 09 14:03:55 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977261, encodeId=fd359e72615f, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Sun Jun 27 12:04:46 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973753, encodeId=4d189e37538e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210615/2ee3fac9632a4d1fb90fb66f0c69d51e/676a24ca6b3948adaaf4522dd9f1a6f7.jpg, createdBy=09995521365, createdName=ms9000001134969034, createdTime=Tue Jun 15 15:59:52 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973664, encodeId=dd679e366410, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ff45503249, createdName=ms2000000300346599, createdTime=Tue Jun 15 10:18:07 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962992, encodeId=bf0696299266, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/deb9cbd849f8496eb91e945a9b30c8c9/47210eaeb9a14963a5f35bdd95998a3c.jpg, createdBy=85962545734, createdName=ddrrrr13, createdTime=Thu May 06 08:40:46 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-06-27 1356548325

    收藏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1078428, encodeId=959510e842884, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/9af4f46ea6004869aea23fabb77f1614/d23125a977bc473e96b379a9b303d1a0.jpg, createdBy=8500100443, createdName=woshibaitu, createdTime=Thu Dec 09 14:03:55 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977261, encodeId=fd359e72615f, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Sun Jun 27 12:04:46 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973753, encodeId=4d189e37538e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210615/2ee3fac9632a4d1fb90fb66f0c69d51e/676a24ca6b3948adaaf4522dd9f1a6f7.jpg, createdBy=09995521365, createdName=ms9000001134969034, createdTime=Tue Jun 15 15:59:52 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973664, encodeId=dd679e366410, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ff45503249, createdName=ms2000000300346599, createdTime=Tue Jun 15 10:18:07 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962992, encodeId=bf0696299266, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/deb9cbd849f8496eb91e945a9b30c8c9/47210eaeb9a14963a5f35bdd95998a3c.jpg, createdBy=85962545734, createdName=ddrrrr13, createdTime=Thu May 06 08:40:46 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-06-15 ms9000001134969034

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1078428, encodeId=959510e842884, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/9af4f46ea6004869aea23fabb77f1614/d23125a977bc473e96b379a9b303d1a0.jpg, createdBy=8500100443, createdName=woshibaitu, createdTime=Thu Dec 09 14:03:55 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977261, encodeId=fd359e72615f, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Sun Jun 27 12:04:46 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973753, encodeId=4d189e37538e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210615/2ee3fac9632a4d1fb90fb66f0c69d51e/676a24ca6b3948adaaf4522dd9f1a6f7.jpg, createdBy=09995521365, createdName=ms9000001134969034, createdTime=Tue Jun 15 15:59:52 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973664, encodeId=dd679e366410, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ff45503249, createdName=ms2000000300346599, createdTime=Tue Jun 15 10:18:07 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962992, encodeId=bf0696299266, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/deb9cbd849f8496eb91e945a9b30c8c9/47210eaeb9a14963a5f35bdd95998a3c.jpg, createdBy=85962545734, createdName=ddrrrr13, createdTime=Thu May 06 08:40:46 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-06-15 ms2000000300346599

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1078428, encodeId=959510e842884, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/9af4f46ea6004869aea23fabb77f1614/d23125a977bc473e96b379a9b303d1a0.jpg, createdBy=8500100443, createdName=woshibaitu, createdTime=Thu Dec 09 14:03:55 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977261, encodeId=fd359e72615f, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Sun Jun 27 12:04:46 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973753, encodeId=4d189e37538e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210615/2ee3fac9632a4d1fb90fb66f0c69d51e/676a24ca6b3948adaaf4522dd9f1a6f7.jpg, createdBy=09995521365, createdName=ms9000001134969034, createdTime=Tue Jun 15 15:59:52 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973664, encodeId=dd679e366410, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ff45503249, createdName=ms2000000300346599, createdTime=Tue Jun 15 10:18:07 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962992, encodeId=bf0696299266, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/deb9cbd849f8496eb91e945a9b30c8c9/47210eaeb9a14963a5f35bdd95998a3c.jpg, createdBy=85962545734, createdName=ddrrrr13, createdTime=Thu May 06 08:40:46 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-05-06 ddrrrr13

    收藏

    0

以上为热门评论，梅斯医学App还有更多内容